Study ID: Alliance A011502
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Bemidji Clinic, Bismarck Region, Fargo Region, Sioux Falls Region
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Breast - Invasive
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.